Drug discovery in pharmaceutical industry: productivity challenges and trends.

  title={Drug discovery in pharmaceutical industry: productivity challenges and trends.},
  author={Ish K Khanna},
  journal={Drug discovery today},
  volume={17 19-20},
Low productivity, rising R&D costs, dissipating proprietary products and dwindling pipelines are driving the pharmaceutical industry to unprecedented challenges and scrutiny. In this article I reflect on the current status of the pharmaceutical industry and reasons for continued low productivity. An emerging 'symbiotic model of innovation', that addresses underlying issues in drug failure and attempts to narrow gaps in current drug discovery processes, is discussed to boost productivity. The… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 4 times over the past 90 days. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.
52 Citations
33 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 52 extracted citations


Publications referenced by this paper.
Showing 1-10 of 33 references

Emerging strategies

  • A. M. Thayer
  • Chem . Eng . News
  • 2011

Reflections on the innovative medicines initiative

  • M. Goldman
  • Nat. Rev. Drug Discov
  • 2011

Shifting generics to the super side

  • Discov
  • Chem . Eng . News
  • 2011

Systematic repositioning using MoA to map all drugs against all diseases

  • A. Persidis
  • 2011

Similar Papers

Loading similar papers…